A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...

Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...

The agreement includes the transfer of regulatory dossiers, manufacturing competencies and technical support to enable GE HealthCare to drive clinical development in Japan, towards potential ...

Prostate cancer stages explain how far cancer has spread. Stage 1 and 2 stay in the prostate and are highly treatable. Stage 3 spreads to nearby tissues, while stage 4 reaches distant organs. PSA ...

AIIMS radiologist stresses importance of early prostate cancer screening, starting at age 50, or earlier for those with risk factors, for effective management.

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery — the ...

The 2025 ASTRO annual meeting featured a prostate cancer radiation toxicity session and a presentation by Dr. Young Suk Kwon discussing an EPIC-26 longitudinal analyses of prostatic urethral lift ...

No patients died of prostate cancer. The 5-year overall survival was 90%.

I am a soon-to-be 85-year-old healthy woman. I take a statin and baby aspirin (I assume because of my age) and have my ...